Murrell, I., Wilkie, G. S., Davison, A. J. , Statkute, E., Fielding, C., Tomasec, P., Wilkinson, G. W.G. and Stanton, R. J. (2016) Genetic stability of bacterial artificial chromosome-derived human cytomegalovirus during culture in vitro. Journal of Virology, 90(8), pp. 3929-3943. (doi: 10.1128/JVI.02858-15) (PMID:26842472) (PMCID:PMC4810542)
|
Text
115568.pdf - Published Version Available under License Creative Commons Attribution. 1MB |
Abstract
Clinical human cytomegalovirus (HCMV) strains invariably mutate when propagated in vitro. Mutations in gene RL13 are selected in all cell types, whereas in fibroblasts mutants in the UL128 locus (UL128L; genes UL128, UL130, and UL131A) are also selected. In addition, sporadic mutations are selected elsewhere in the genome in all cell types. We sought to investigate conditions under which HCMV can be propagated without incurring genetic defects. Bacterial artificial chromosomes (BACs) provide a stable, genetically-defined source of viral genome. Viruses were generated from BACs containing the genomes of strains TR, TB40, FIX, and Merlin, as well as from Merlin-BAC recombinants containing variant nucleotides in UL128L from TB40-BAC4 or FIX-BAC. Propagation of viruses derived from TR-BAC, TB40-BAC4, and FIX-BAC in either fibroblast or epithelial cells was associated with the generation of defects around the prokaryotic vector, which is retained in the US region of viruses. This was not observed for Merlin-BAC, from which the vector is excised in derived viruses, however propagation in epithelial cells was consistently associated with mutations in the UL/b' region, all impacting on gene UL141. Viruses derived from Merlin-BAC in fibroblasts mutated in UL128L, but this occurred less frequently with recombinants containing UL128L nucleotides from TB40-BAC4 or FIX-BAC. Viruses derived from a Merlin-BAC derivative in which RL13 and UL128L were either mutated or repressed were remarkably stable in fibroblasts. Thus, HCMV containing a wild-type gene complement can be generated in vitro by deriving virus from a self-excising BAC in fibroblasts, and repressing RL13 and UL128L.
| Item Type: | Articles |
|---|---|
| Additional Information: | This work was supported by the Medical Research Council (grant numbers MC_UU_12014/3, MR/L018373/1, MR/L008734/1), the Wellcome Trust (grant number WT090323), and NRN Ser Cymru. |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Wilkie, Dr Gavin and Davison, Professor Andrew |
| Authors: | Murrell, I., Wilkie, G. S., Davison, A. J., Statkute, E., Fielding, C., Tomasec, P., Wilkinson, G. W.G., and Stanton, R. J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
| Journal Name: | Journal of Virology |
| Publisher: | American Society for Microbiology |
| ISSN: | 0022-538X |
| ISSN (Online): | 1098-5514 |
| Published Online: | 03 February 2016 |
| Copyright Holders: | Copyright © 2016 Murrell et al. |
| First Published: | First published in Journal of Virology 90(8):3929-3943 |
| Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information